Ovulation and extra-ovarian origin of ovarian cancer

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Yang Hartwich, Yang ^a   Gurrea Soteras, Marta ^a   Sumi, Natalia ^a   Joo, Won Duk ^b   Holmberg, Jennie C ^a   Craveiro, Vinicius ^a   Alvero, Ayesha B ^a   Mor, Gil ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHA University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; CANCER STEM CELL; CARCINOMA; CELL MOTION; CELL TRANSFORMATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; FEMALE; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; OVARY TUMOR; OVULATION; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSPLANTATION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; OVULATION; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84906558619     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06116     Document Type: Article

References (51)

1. Siegel, R.,Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9-29 (2014).
2. Lee, Y. et al.Acandidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 211, 26-35 (2007). (Pubitemid 46092026)
3. Leonhardt, K., Einenkel, J., Sohr, S., Engeland, K. & Horn, L. C. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Int J Gynecol Pathol 30, 417-24 (2011).
4. Norquist, B. M. et al. The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations. Cancer 116, 5261-71 (2010).
5. Folkins, A. K. et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol 109, 168-73 (2008).
6. Marquez, R. T. et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res 11, 6116-26 (2005). (Pubitemid 41262937)
7. Khunamornpong, S., Suprasert, P., Chiangmai, W. N. & Siriaunkgul, S. Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand. Int J Gynecol Cancer 16 Suppl 1, 132-8 (2006).
8. Lee, K. R. & Nucci, M. R. Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: a clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis. Int J Gynecol Pathol 22, 42-51 (2003). (Pubitemid 36014275)
9. Kamran, M. W. et al. Opportunistic and interventional salpingectomy in women at risk: a strategy for preventing pelvic serous cancer (PSC). Eur J Obstet Gynecol Reprod Biol 170, 251-4 (2013).
10. Richards, J. S., Russell, D. L., Ochsner, S.&Espey, L. L. Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu Rev Physiol 64, 69-92 (2002). (Pubitemid 34259226)
11. Purdie, D. M., Bain, C. J., Siskind, V.,Webb, P. M. & Green, A. C. Ovulation and risk of epithelial ovarian cancer. Int J Cancer 104, 228-32 (2003). (Pubitemid 36249799)
12. Tung, K. H. et al. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol 161, 321-9 (2005).
13. Craveiro, V. et al. Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment. Cancer Med 2, 751-62 (2013).
14. Machelon, V. & Emilie, D. Production of ovarian cytokines and their role in ovulation in the mammalian ovary. Eur Cytokine Netw 8, 137-43 (1997). (Pubitemid 28152139)
15. Zuccarello, D. et al. How the human spermatozoa sense the oocyte: a new role of SDF1-CXCR4 signalling. Int J Androl 34, e554-65 (2011).
16. Ratajczak, M. Z. et al. A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients. Leukemia 26, 63-72 (2012).
17. Greenbaum, A. et al. CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature 495, 227-30 (2013).
18. Barbolina, M. V. et al. Microenvironmental regulation of chemokine (C-X-Cmotif) receptor 4 in ovarian carcinoma. Mol Cancer Res 8, 653-64 (2010).
19. Popple, A. et al. The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer. Br J Cancer 106, 1306-13 (2012).
20. Nishi, Y. et al. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142, 437-45 (2001). (Pubitemid 32183706)
21. Wojcechowskyj, J. A., Lee, J. Y., Seeholzer, S. H. & Doms, R. W. Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling. PLoS One 6, e24918 (2011).
22. Hunt, J. S. Expression and regulation of the tumour necrosis factor-alpha gene in the female reproductive tract. Reprod Fertil Dev 5, 141-53 (1993).
23. Murdoch,W. J., Colgin, D. C. & Ellis, J. A. Role of tumor necrosis factor-alpha in the ovulatory mechanism of ewes. J Anim Sci 75, 1601-5 (1997). (Pubitemid 127443309)
24. Rodgers, R. J. & Irving-Rodgers, H. F. The roles of the ovarian extracellular matrix in fertility. Soc Reprod Fertil Suppl 67, 217-30 (2010).
25. Rodgers, R. J., Irving-Rodgers, H. F. & Russell, D. L. Extracellular matrix of the developing ovarian follicle. Reproduction 126, 415-24 (2003). (Pubitemid 37369602)
26. Carmeliet, G.,Himpens, B.&Cassiman, J. J. Selective increase in the binding of the alpha 1 beta 1 integrin for collagen type IV during neurite outgrowth of human neuroblastoma TR 14 cells. J Cell Sci 107 (Pt 12), 3379-92 (1994).
27. Katoh, D. et al. Binding of alphavbeta1 and alphavbeta6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells. Oncogenesis 2, e65 (2013).
28. Tuckwell, D. & Humphries, M. Integrin-collagen binding. Seminars in Cell & Developmental Biology 7, 649-657 (1996). (Pubitemid 126320625)
29. Crum, C. P. et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19, 3-9 (2007). (Pubitemid 46095865)
30. Crum, C. P. et al. Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer. J Pathol 231, 402-12 (2013).
31. Crum, C. P., McKeon, F. D.&Xian, W. BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis. Int J Gynecol Cancer 22 Suppl 1, S29-34 (2012).
32. Kim, J. et al. High-grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci U S A 109, 3921-6 (2012).
33. Perets, R. et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca; Tp53; Pten models. Cancer Cell 24, 751-65 (2013).
34. Sale, S. & Orsulic, S. Models of ovarian cancer metastasis: Murine models. Drug Discov Today Dis Models 3, 149-154 (2006).
35. Alvero, A. B. et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8, 158-66 (2009).
36. Chen, R. et al. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 27, 4712-23 (2008).
37. Alvero, A. B. et al. Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 27, 2405-13 (2009).
38. Yin, G. et al. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 29, 3545-53 (2010).
39. Alvero, A. B. et al. Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells. Mol Cancer Ther 10, 1385-93 (2011).
40. Chefetz, I., Holmberg, J. C., Alvero, A. B., Visintin, I. & Mor, G. Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFkB pathway. Cell Cycle 10, 2206-14 (2011).
41. Alvero, A. B., Montagna, M. K., Craveiro, V., Liu, L. & Mor, G. Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype. Am J Reprod Immunol 67, 256-65 (2012).
42. Chefetz, I. et al. TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence. Cell Cycle 12, 511-21 (2013).
43. Yin, G. et al. Constitutive proteasomal degradation of TWIST-1 in epithelialovarian cancer stem cells impacts differentiation and metastatic potential. Oncogene 32, 39-49 (2013).
44. Ara, T. et al. Impaired colonization of the gonads by primordial germ cells in mice lacking a chemokine, stromal cell-derived factor-1 (SDF-1). Proc Natl Acad SciUS A 100, 5319-23 (2003). (Pubitemid 36542703)
45. Holt, J. E. et al. CXCR4/SDF1 interaction inhibits the primordial to primary follicle transition in the neonatal mouse ovary. Dev Biol 293, 449-60 (2006).
46. Park, M. J. et al. Expression of SDF-1alpha and leptin, and their effect on expression of angiogenic factors in mouse ovaries. Clin Exp Reprod Med 38, 135-41 (2011).
47. Kamsteeg, M. et al. Phenoxodiol-an isoflavone analog-induces apoptosis in chemoresistant ovarian cancer cells. Oncogene 22, 2611-20 (2003). (Pubitemid 36605609)
48. Roby, K. F. et al. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21, 585-91 (2000). (Pubitemid 30214011)
49. Xia, X. et al. Fluorescence in situ hybridization using an old world monkey Y chromosome specific probe combined with immunofluorescence staining on rhesus monkey tissues. J Histochem Cytochem 55, 1115-21 (2007). (Pubitemid 350006293)
50. Abrahams, V. M. et al. A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 175, 8096-104 (2005). (Pubitemid 41798372)
51. Bass, M. D. et al. Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix. J Cell Biol 177, 527-38 (2007). (Pubitemid 46718280)